A longitudinal comparison of retention in buprenorphine and methadone treatment for opioid dependence in New South Wales, Australia
Saved in:
Burns, L., et al., A longitudinal comparison of retention in buprenorphine and methadone treatment for opioid dependence in New South Wales, Australia. Addiction, vol. 110, n. 4, 2015, p. 646-655.
Ref.
499894
Location:
SIIS Archivo R.696
Palabras clave:
Drogodependencias, Drogas ilegales, Opiáceos, Tratamiento médico, Reducción de daños, Programas de mantenimiento, Metadona, Buprenorfina, Efectos, Retención, Australia
Drogodependencias, Drogas ilegales, Opiáceos, Tratamiento médico, Reducción de daños, Programas de mantenimiento, Metadona, Buprenorfina, Efectos, Retención, Australia
Similar Items: A longitudinal comparison of retention in buprenorphine and methadone treatment for opioid dependence in New South Wales, Australia
- PREVALENCE OF DIVERSION AND INJECTION OF METHADONE AND BUPRENORPHINE AMONG CLIENTS RECEIVING OPIOID TREATMENT AT COMMUNITY PHARMACIES IN NEW SOUTH WALES, AUSTRALIA
- OPIOID AGONIST PHARMACOTHERAPY IN NEW SOUTHWALES FROM 1985 TO 2006: PATIENT CHARACTERISTICS AND PATTERNS AND PREDICTORS OF TREATMENT RETENTION
- SUBSTITUTION PHARMACOTHERAPIES FOR OPIOID ADDICTION: FROM METHADONE TO LAAM AND BUPRENORPHINE
- TREATMENT RETENTION IN ADOLESCENT PATIENTS TREATED WITH METHADONE OR BUPRENORPHINE FOR OPIOID DEPENDENCE: A FILE REVIEW
- Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trial
- DIVERSION AND INJECTION OF METHADONE AND BUPRENORPHINE AMONG CLIENTS IN PUBLIC OPIOID TREATMENT CLINICS IN NEW SOUTH WALES, AUSTRALIA